医薬品安定保管サービスの世界市場レポート 2025年

医薬品安定保管サービス市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.5％で36億5,000万米ドルに成長します。予測期間中に予測される成長は、個別化医療の台頭、コールドチェーンロジスティクスの拡大、バイオ医薬品パイプラインの増加、生物学的製剤の承認増加、安定性試験の需要増などに起因しています。この期間の主な動向には、技術の進歩、極低温貯蔵技術の進歩、デジタルモニタリング技術の開発、パッケージング技術の革新、温度制御貯蔵システムの進歩などがあります。

新薬の承認件数の増加が、今後の医薬品安定保管サービス市場の拡大を牽引すると予想されます。新薬とは、過去に承認・上市されたことのない、新たに開発された医薬化合物のことです。新薬承認数の急増は、新規化合物の発見を可能にしたバイオテクノロジーの進歩と、より迅速で効率的な医薬品開発を促進する規制プロセスの改善によるところが大きいです。新薬承認の増加は、これらの製品の適切な条件、コンプライアンス、長期保存管理を保証する医薬品安定保管サービスの需要を押し上げます。例えば、2023年10月、米国食品医薬品局（FDA）は、2022年に37の新薬が承認され、2024年には50の新薬が承認され、がん、希少疾患、神経学、感染症、統合失調症、疼痛、アルツハイマー病などの治療が前進したと報告しました。このように、新薬の承認件数の増加が医薬品安定保管サービス市場の成長を促進しています。

医薬品安定保管サービス市場の主要企業は、温度に敏感な医薬品の保存性を向上させるため、極低温保存スイートなどの技術的に高度なソリューションの開発に注力しています。極低温保存スイートは、細胞療法、ワクチン、生物製剤などの温度に敏感な生物学的・医薬学的材料を保存するために、通常-150℃以下の極低温を維持する専門施設です。例えば、2024年12月、英国を拠点とする安定性と生物試料の保管会社であるAstoriom社は、アイルランドのウォーターフォード州にあるトラモア施設に極低温保管スイートを発表しました。この拡張により、生物試料の保管能力が大幅に強化され、-196℃までの精密な温度制御、大容量の保管、規制遵守のためのISO9001認証、安全な長期保存を保証するためのアクセス制御や監視システムなどの高度なセキュリティ機能が提供されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界医薬品安定保管サービス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の医薬品安定保管サービス市場：成長率分析
• 世界の医薬品安定保管サービス市場の実績：規模と成長, 2019-2024
• 世界の医薬品安定保管サービス市場の予測：規模と成長, 2024-2029, 2034F
• 世界医薬品安定保管サービス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医薬品安定保管サービス市場：サービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 安定性
• ストレージ
• 世界の医薬品安定保管サービス市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• カプセル
• 注射液
• 経口懸濁液
• 組み合わせ製品
• その他の製品タイプ
• 世界の医薬品安定保管サービス市場分子による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小分子
• 巨大分子
• 世界の医薬品安定保管サービス市場モード別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 社内
• アウトソーシング
• 世界の医薬品安定保管サービス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• バイオ医薬品企業
• 契約製造組織
• 契約調査機関
• その他のエンドユーザー
• 世界の医薬品安定保管サービス市場、安定化サービスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 長期安定性試験
• 加速安定性試験
• 中間安定性試験
• 光安定性試験
• 強制劣化研究
• 世界の医薬品安定保管サービス市場ストレージサービスのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 常温保存
• 冷蔵保存（2℃～8℃）
• 冷凍保存（-20℃～-80℃）
• 極低温保管（-150℃～-196℃）
• 規制薬物物質および製品の保管

第7章 地域別・国別分析

• 世界の医薬品安定保管サービス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の医薬品安定保管サービス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品安定保管サービス市場：競合情勢
• 医薬品安定保管サービス市場：企業プロファイル
  • Cencora Inc Overview, Products and Services, Strategy and Financial Analysis
  • SGS S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • Catalent Inc Overview, Products and Services, Strategy and Financial Analysis
  • Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Intertek Group plc
• Element Materials Technology Inc
• Alloga UK Ltd.
• ALS Limited
• Pharmaceutical Contract Industries Pharma Services.
• Almac Group
• Alcami Corporation
• BioLife Solutions Inc.
• Auriga Research Private Limited
• Reading Scientific Services Ltd.
• Lucideon Limited
• Q Laboratories Inc
• PD Partners
• Precision Stability Storage
• Roylance Stability Storage Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 医薬品安定保管サービス市場2029：新たな機会を提供する国
• 医薬品安定保管サービス市場2029：新たな機会を提供するセグメント
• 医薬品安定保管サービス市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pharmaceutical stability and storage services are specialized offerings designed to ensure that pharmaceutical products, including drugs, medications, and vaccines, retain their quality, efficacy, and safety throughout their shelf life. These services involve maintaining controlled storage environments, conducting stability studies to monitor chemical, physical, and microbiological changes, and ensuring compliance with regulatory standards.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary pharmaceutical stability and storage services include stability testing and storage solutions. Stability services evaluate how pharmaceutical products maintain their quality, potency, and safety under varying environmental conditions over time. These services apply to various products such as tablets, capsules, injectable solutions, oral suspensions, combination products, and others, and can involve both small and large molecules. Stability and storage services are provided through in-house and outsourcing models, and are utilized by biopharmaceutical companies, contract manufacturing organizations, contract research organizations, and other entities.

The pharmaceutical stability and storage services market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical stability and storage services market statistics, including pharmaceutical stability and storage services industry global market size, regional shares, competitors with a pharmaceutical stability and storage services market share, detailed pharmaceutical stability and storage services market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical stability and storage services industry. This pharmaceutical stability and storage services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical stability and storage services market size has grown strongly in recent years. It will grow from $2.66 billion in 2024 to $2.84 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth observed during the historic period can be attributed to the rising demand for biologics, the increasing prevalence of chronic diseases, growth in drug development, the growing complexity of drug formulations, and heightened research and development efforts within the pharmaceutical industry.

The pharmaceutical stability and storage services market size is expected to see strong growth in the next few years. It will grow to $3.65 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth projected during the forecast period can be attributed to the rise of personalized medicine, the expansion of cold chain logistics, a growing biopharma pipeline, increasing biologic drug approvals, and a higher demand for stability testing. Key trends during this period include technological advancements, progress in cryogenic storage technologies, developments in digital monitoring technologies, innovations in packaging technologies, and the advancement of temperature-controlled storage systems.

The growing number of novel drug approvals is expected to drive the expansion of the pharmaceutical stability and storage services market in the future. A novel drug is a newly developed pharmaceutical compound that has not been previously approved for use or marketed. The surge in novel drug approvals is largely attributed to advancements in biotechnology, which have enabled the discovery of new compounds, as well as improvements in regulatory processes that facilitate faster and more efficient drug development. The increase in novel drug approvals boosts the demand for pharmaceutical stability and storage services, which ensure the proper conditions, compliance, and extended shelf-life management of these products. For example, in October 2023, the U.S. Food and Drug Administration (FDA) reported that 37 novel drugs were approved in 2022, followed by 50 in 2024, advancing treatments in areas such as cancer, rare diseases, neurology, infections, and conditions such as schizophrenia, pain, and Alzheimer's. As such, the rising number of novel drug approvals is fueling the growth of the pharmaceutical stability and storage services market.

Leading companies in the pharmaceutical stability and storage services market are focusing on the development of technologically advanced solutions, such as cryogenic storage suites, to improve the preservation of temperature-sensitive pharmaceutical products. Cryogenic storage suites are specialized facilities that maintain extremely low temperatures, typically below -150°C, to preserve temperature-sensitive biological and pharmaceutical materials such as cell therapies, vaccines, and biologics. For instance, in December 2024, Astoriom, a UK-based stability and biospecimen storage company, unveiled a cryogenic storage suite at its Tramore facility in County Waterford, Ireland. This expansion significantly enhances its capacity to store biological samples, offering precise temperature control down to -196°C, large storage capacity, ISO 9001 certification for regulatory compliance, and advanced security features, such as access controls and monitoring systems, to ensure safe long-term preservation.

In June 2022, Cambrex Corporation, a US-based contract development and manufacturing organization, acquired Q1 Scientific for an undisclosed amount. This acquisition allows Cambrex to expand its presence in Europe, bolster its stability storage service capabilities, and strengthen its portfolio of outsourced pharmaceutical solutions to meet the growing demands of the industry. Q1 Scientific Limited, based in Ireland, specializes in providing pharmaceutical stability and storage services.

Major players in the pharmaceutical stability and storage services market are Cencora Inc, SGS S.A., Eurofins Scientific SE, Catalent Inc, Charles River Laboratories, Intertek Group plc, Element Materials Technology Inc, Alloga UK Ltd., ALS Limited, Pharmaceutical Contract Industries Pharma Services., Almac Group, Alcami Corporation, BioLife Solutions Inc., Auriga Research Private Limited, Reading Scientific Services Ltd., Lucideon Limited, Q Laboratories Inc, PD Partners, Precision Stability Storage, Roylance Stability Storage Limited.

North America was the largest region in the pharmaceutical stability and storage services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical stability and storage services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical stability and storage services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical stability and storage services market consists of revenues earned by entities by providing services such as photostability testing, cold chain management, disaster recovery and backup storage. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical stability and storage services market also includes sales of stability chambers, cryogenic storage systems, cold storage units and automated sample management systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Stability And Storage Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical stability and storage services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical stability and storage services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical stability and storage services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Service: Stability; Storage
• 2) By Product Type: Tablets; Capsules; Injectable Solutions; Oral Suspensions; Combination Products; Other Product Types
• 3) By Molecule: Small Molecule; Large Molecule
• 4) By Mode: In-House; Outsourcing
• 5) By End User: Biopharmaceutical Companies; Contract Manufacturing Organizations; Contract Research Organizations; Other End Users
• Subsegments:
• 1) Stability Services: Long-Term Stability Studies; Accelerated Stability Studies; Intermediate Stability Studies; Photostability Testing; Forced Degradation Studies
• 2) Storage Services: Ambient Storage; Refrigerated Storage (2°C to 8°C); Frozen Storage (-20°C to -80°C); Cryogenic Storage (-150°C to -196°C); Controlled Drug Substance And Product Storage
• Companies Mentioned: Cencora Inc; SGS S.A.; Eurofins Scientific SE; Catalent Inc; Charles River Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Stability And Storage Services Market Characteristics

3. Pharmaceutical Stability And Storage Services Market Trends And Strategies

4. Pharmaceutical Stability And Storage Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmaceutical Stability And Storage Services Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceutical Stability And Storage Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceutical Stability And Storage Services Market Growth Rate Analysis
• 5.4. Global Pharmaceutical Stability And Storage Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceutical Stability And Storage Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceutical Stability And Storage Services Total Addressable Market (TAM)

6. Pharmaceutical Stability And Storage Services Market Segmentation

• 6.1. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stability
• Storage
• 6.2. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsules
• Injectable Solutions
• Oral Suspensions
• Combination Products
• Other Product Types
• 6.3. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Small Molecule
• Large Molecule
• 6.4. Global Pharmaceutical Stability And Storage Services Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In-House
• Outsourcing
• 6.5. Global Pharmaceutical Stability And Storage Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biopharmaceutical Companies
• Contract Manufacturing Organizations
• Contract Research Organizations
• Other End Users
• 6.6. Global Pharmaceutical Stability And Storage Services Market, Sub-Segmentation Of Stability Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Long-Term Stability Studies
• Accelerated Stability Studies
• Intermediate Stability Studies
• Photostability Testing
• Forced Degradation Studies
• 6.7. Global Pharmaceutical Stability And Storage Services Market, Sub-Segmentation Of Storage Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ambient Storage
• Refrigerated Storage (2°C to 8°C)
• Frozen Storage (-20°C to -80°C)
• Cryogenic Storage (-150°C to -196°C)
• Controlled Drug Substance And Product Storage

7. Pharmaceutical Stability And Storage Services Market Regional And Country Analysis

• 7.1. Global Pharmaceutical Stability And Storage Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceutical Stability And Storage Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Stability And Storage Services Market

• 8.1. Asia-Pacific Pharmaceutical Stability And Storage Services Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Stability And Storage Services Market

• 9.1. China Pharmaceutical Stability And Storage Services Market Overview
• 9.2. China Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Stability And Storage Services Market

• 10.1. India Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Stability And Storage Services Market

• 11.1. Japan Pharmaceutical Stability And Storage Services Market Overview
• 11.2. Japan Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Stability And Storage Services Market

• 12.1. Australia Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Stability And Storage Services Market

• 13.1. Indonesia Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Stability And Storage Services Market

• 14.1. South Korea Pharmaceutical Stability And Storage Services Market Overview
• 14.2. South Korea Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Stability And Storage Services Market

• 15.1. Western Europe Pharmaceutical Stability And Storage Services Market Overview
• 15.2. Western Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Stability And Storage Services Market

• 16.1. UK Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Stability And Storage Services Market

• 17.1. Germany Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Stability And Storage Services Market

• 18.1. France Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Stability And Storage Services Market

• 19.1. Italy Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Stability And Storage Services Market

• 20.1. Spain Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Stability And Storage Services Market

• 21.1. Eastern Europe Pharmaceutical Stability And Storage Services Market Overview
• 21.2. Eastern Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Stability And Storage Services Market

• 22.1. Russia Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Stability And Storage Services Market

• 23.1. North America Pharmaceutical Stability And Storage Services Market Overview
• 23.2. North America Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Stability And Storage Services Market

• 24.1. USA Pharmaceutical Stability And Storage Services Market Overview
• 24.2. USA Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Stability And Storage Services Market

• 25.1. Canada Pharmaceutical Stability And Storage Services Market Overview
• 25.2. Canada Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Stability And Storage Services Market

• 26.1. South America Pharmaceutical Stability And Storage Services Market Overview
• 26.2. South America Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Stability And Storage Services Market

• 27.1. Brazil Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Stability And Storage Services Market

• 28.1. Middle East Pharmaceutical Stability And Storage Services Market Overview
• 28.2. Middle East Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Stability And Storage Services Market

• 29.1. Africa Pharmaceutical Stability And Storage Services Market Overview
• 29.2. Africa Pharmaceutical Stability And Storage Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceutical Stability And Storage Services Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceutical Stability And Storage Services Market, Segmentation By Molecule, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Stability And Storage Services Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceutical Stability And Storage Services Market Competitive Landscape
• 30.2. Pharmaceutical Stability And Storage Services Market Company Profiles
  • 30.2.1. Cencora Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. SGS S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Catalent Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Charles River Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Stability And Storage Services Market Other Major And Innovative Companies

• 31.1. Intertek Group plc
• 31.2. Element Materials Technology Inc
• 31.3. Alloga UK Ltd.
• 31.4. ALS Limited
• 31.5. Pharmaceutical Contract Industries Pharma Services.
• 31.6. Almac Group
• 31.7. Alcami Corporation
• 31.8. BioLife Solutions Inc.
• 31.9. Auriga Research Private Limited
• 31.10. Reading Scientific Services Ltd.
• 31.11. Lucideon Limited
• 31.12. Q Laboratories Inc
• 31.13. PD Partners
• 31.14. Precision Stability Storage
• 31.15. Roylance Stability Storage Limited

32. Global Pharmaceutical Stability And Storage Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Stability And Storage Services Market

34. Recent Developments In The Pharmaceutical Stability And Storage Services Market

35. Pharmaceutical Stability And Storage Services Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceutical Stability And Storage Services Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceutical Stability And Storage Services Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceutical Stability And Storage Services Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34925_Pharmaceutical_Stability_And_Storage_Services_GMR_2025